ANEB
Price
$1.80
Change
+$0.16 (+9.76%)
Updated
Jul 21 closing price
Capitalization
73.95M
57 days until earnings call
IMUC
Price
$0.08
Change
-$0.00 (-0.00%)
Updated
Jul 21 closing price
Capitalization
9.87M
Interact to see
Advertisement

ANEB vs IMUC

Header iconANEB vs IMUC Comparison
Open Charts ANEB vs IMUCBanner chart's image
Anebulo Pharmaceuticals
Price$1.80
Change+$0.16 (+9.76%)
Volume$11.49K
Capitalization73.95M
EOM Pharmaceutical Holdings
Price$0.08
Change-$0.00 (-0.00%)
Volume$1.01K
Capitalization9.87M
ANEB vs IMUC Comparison Chart in %
Loading...
ANEB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMUC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANEB vs. IMUC commentary
Jul 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANEB is a Hold and IMUC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 22, 2025
Stock price -- (ANEB: $1.80 vs. IMUC: $0.08)
Brand notoriety: ANEB and IMUC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANEB: 80% vs. IMUC: 52%
Market capitalization -- ANEB: $73.95M vs. IMUC: $9.87M
ANEB [@Biotechnology] is valued at $73.95M. IMUC’s [@Biotechnology] market capitalization is $9.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANEB’s FA Score shows that 0 FA rating(s) are green whileIMUC’s FA Score has 1 green FA rating(s).

  • ANEB’s FA Score: 0 green, 5 red.
  • IMUC’s FA Score: 1 green, 4 red.
According to our system of comparison, ANEB is a better buy in the long-term than IMUC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANEB’s TA Score shows that 3 TA indicator(s) are bullish while IMUC’s TA Score has 4 bullish TA indicator(s).

  • ANEB’s TA Score: 3 bullish, 5 bearish.
  • IMUC’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, IMUC is a better buy in the short-term than ANEB.

Price Growth

ANEB (@Biotechnology) experienced а +11.80% price change this week, while IMUC (@Biotechnology) price change was +0.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.39%. For the same industry, the average monthly price growth was +15.71%, and the average quarterly price growth was +33.77%.

Reported Earning Dates

ANEB is expected to report earnings on Sep 17, 2025.

Industries' Descriptions

@Biotechnology (+2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANEB($74M) has a higher market cap than IMUC($9.87M). ANEB YTD gains are higher at: 7.143 vs. IMUC (-53.791). ANEB has more cash in the bank: 13.3M vs. IMUC (85.3K).
ANEBIMUCANEB / IMUC
Capitalization74M9.87M750%
EBITDA-7.27MN/A-
Gain YTD7.143-53.791-13%
P/E RatioN/A0.02-
Revenue0N/A-
Total Cash13.3M85.3K15,592%
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
IMUC: Fundamental Ratings
IMUC
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANEBIMUC
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
76%
Momentum
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
66%
MACD
ODDS (%)
Bearish Trend 4 days ago
80%
Bullish Trend 4 days ago
65%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 4 days ago
58%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 8 days ago
60%
Declines
ODDS (%)
Bearish Trend 7 days ago
86%
Bearish Trend 20 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
86%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 6 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ANEB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMUC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LLKKF0.03N/A
+12.72%
Lake Resources N.L.
SLRK9.080.02
+0.22%
Solera National Bancorp, Inc.
PBNNF0.20N/A
N/A
PT Bank Negara Indonesia TBK
EQTL1.00N/A
N/A
Equitech Int'l Corp.
MCSHF2.85N/A
N/A
Metcash Ltd.

ANEB and

Correlation & Price change

A.I.dvisor tells us that ANEB and ABCZF have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ANEB and ABCZF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANEB
1D Price
Change %
ANEB100%
+9.76%
ABCZF - ANEB
31%
Poorly correlated
N/A
ALDX - ANEB
28%
Poorly correlated
N/A
SRPT - ANEB
24%
Poorly correlated
-5.36%
RLAY - ANEB
23%
Poorly correlated
+3.71%
IMUC - ANEB
23%
Poorly correlated
-2.50%
More

IMUC and

Correlation & Price change

A.I.dvisor tells us that IMUC and ANEB have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IMUC and ANEB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMUC
1D Price
Change %
IMUC100%
-2.50%
ANEB - IMUC
23%
Poorly correlated
+9.76%
VNDA - IMUC
22%
Poorly correlated
-2.51%
STTK - IMUC
21%
Poorly correlated
-5.10%
CCCC - IMUC
21%
Poorly correlated
-2.16%
PRTA - IMUC
8%
Poorly correlated
+0.48%
More